XML 37 R26.htm IDEA: XBRL DOCUMENT
v3.25.2

NATURE OF OPERATIONS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Schedule of concentration risk |
Schedule of concentration risk |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Schedule of concentration risk |  | June 30, |  |  |  |  |  |  |  |  |
|  | 2025 |  |  | 2024 |  |  |  |  |  |  |  |  |
Assets - Serbia |  | $ | 21,474 |  |  | $ | 24,553 |  |  |  |  |  |  |  |  |
Assets - U.S. |  |  | 25,270 |  |  |  | 47,361 |  |  |  |  |  |  |  |  |
Total Assets |  | $ | 46,744 |  |  | $ | 71,914 |  |  |  |  |  |  |  |  |
Liabilities - Serbia |  | $ | 12,037 |  |  | $ | 10,234 |  |  |  |  |  |  |  |  |
Liabilities - U.S. |  |  | 7,815 |  |  |  | 18,283 |  |  |  |  |  |  |  |  |
Total Liabilities |  | $ | 19,852 |  |  | $ | 28,517 |  |  |  |  |  |  |  |  |
|  | Three Months Ended |  |  | Six Months Ended |
|  | June 30, |  |  | June 30, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Sales - Serbia |  | $ | 3,300 |  |  | $ | 2,771 |  |  | $ | 4,826 |  |  | $ | 4,200 |
Sales - U.S. |  |  | 3,775 |  |  |  | 12,041 |  |  |  | 8,573 |  |  |  | 25,173 |
Total Revenues |  | $ | 7,075 |  |  | $ | 14,812 |  |  | $ | 13,399 |  |  | $ | 29,373 |
Net Income/(Loss) - Serbia |  | $ | 691 |  |  | $ | (425 | ) |  | $ | (6,000 | ) |  | $ | (798 | )
Net Loss - U.S. |  |  | (4,969 | ) |  |  | (4,491 | ) |  |  | (13,801 | ) |  |  | (7,155 | )
Total Net Loss |  | $ | (4,278 | ) |  | $ | (4,916 | ) |  | $ | (19,801 | ) |  | $ | (7,953 | )
Schedule of accounts receivable |
Schedule of accounts receivable |  |  |  |  |  |  |  |
|  | June 30, |  |  | December 31, |
(Dollars in thousands) |  | 2025 |  |  | 2024 |
Allowance for credit losses: |  |  |  |  |  |  |  |
Beginning of period |  | $ | 259 |  |  | $ | 448 |
Net provision for credit losses |  |  | 252 |  |  |  | (72 | )
(Charge-offs)/recoveries, net |  |  | – |  |  |  | (117 | )
End of Period |  | $ | 511 |  |  | $ | 259 |
Schedule of contingent consideration |
Schedule of contingent consideration |  |  |  |  |  |  |  |  |
|  | Level 1 |  |  | Level 2 |  |  | Level 3 |
Contingent Consideration as of December 31, 2024 |  |  | – |  |  |  | – |  |  | $ | 309 |
Additions |  |  |  |  |  |  |  |  |  |  | – |
Change in fair value |  |  |  |  |  |  |  |  |  |  | 93 |
Contingent Consideration as of June 30, 2025 |  |  | – |  |  |  | – |  |  | $ | 216 |
Schedule of anti-dilutive |
Schedule of anti-dilutive |  |  |  |  |  |  |  |
|  | June 30, |
|  | 2025 |  |  | 2024 |
Stock Options |  |  | 639,904 |  |  |  | 594,558 |
Warrants |  |  | 200,000 |  |  |  | 200,000 |
Total Shares |  |  | 839,904 |  |  |  | 794,558 |

X
- Definition Tabular disclosure of all significant concentrations of risk, including credit risk and market risk, arising from all financial instruments (as defined), whether from an individual counterparty or groups of counterparties. The disclosure concerning concentrations of risk may consist of the following information: (1) for concentrations of credit risk disclosure may include: (a) information about the (shared) activity, region, or economic characteristic that identifies the concentration, (b) the maximum amount of loss due to credit risk that, based on the gross fair value of the financial instrument, the entity would incur if parties to the financial instruments that make up the concentration failed completely to perform according to the terms of the contracts and the collateral or other security, if any, for the amount due proved to be of no value to the entity, (c) the policy of requiring collateral or other security to support financial instruments subject to credit risk, information about the entity's access to that collateral or other security, and the nature and a brief description of the collateral or other security supporting those financial instruments, and (d) the policy of entering into master netting arrangements to mitigate the credit risk of financial instruments, information about the arrangements for which the entity is a party, and a brief description of the terms of those arrangements, including the extent to which they would reduce the entity's maximum amount of loss due to credit risk and (2) for disclosure of quantitative information about the market risks of financial instruments that is consistent with the way the company manages or adjusts those risks, disclosure may include: (a) more details about current positions and perhaps activity during the period, (b) the hypothetical effects on comprehensive income (or net assets), or annual income, of several possible changes in market prices, (c) a gap analysis of interest rate re-pricing or maturity dates, (d) the duration of the financial instruments, (e) the entity's value at risk from derivatives and from other positions at the end of the reporting period and the average value at risk during the year, or (f) other ways of reporting quantitative information as internally developed. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-20 Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 23 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-23 + Details
Name: | us-gaap_FairValueConcentrationOfRiskTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of liabilities measured at fair value measured on a recurring or nonrecurring basis. Includes, but is not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration